🇺🇸 FDA
Patent

US 9387249

Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone

granted A61KA61K31/404A61K31/41

Quick answer

US patent 9387249 (Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone) held by Takeda Pharmaceutical Company Limited expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/404, A61K31/41, A61K31/4184, A61K31/4245